Previous Article in Journal
Does Ortho-Substitution Enhance Cytotoxic Potencies in a Series of 3,5-Bis(benzylidene)-4-piperidones?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

Safety Implications of Off-Label Medication Use in Athletes: A Narrative Review

1
Unidade Local de Saúde (ULS) de Coimbra, 3004-561 Coimbra, Portugal
2
Polytechnic Institute of Coimbra, Coimbra Health School, Farmácia, 3046-854 Coimbra, Portugal
3
QLV Research Consulting, 3030-193 Coimbra, Portugal
*
Author to whom correspondence should be addressed.
Medicines 2024, 11(8), 20; https://doi.org/10.3390/medicines11080020
Submission received: 22 August 2024 / Revised: 26 October 2024 / Accepted: 7 November 2024 / Published: 15 November 2024

Abstract

In recent years, the off-label use of medications in sports has increased significantly, primarily driven by psychological and social factors. Athletes frequently misuse drugs without adequate medical supervision, relying on unreliable sources of information, which leads to improper usage and serious health risks. This narrative review analyzes literature from PubMed® (Medline), Scopus®, and Web of Science® databases, focusing on studies up to December 2023, to examine the safety concerns related to off-label drug use in sports. The review presents an overview of the off-label use of pharmacological substances by athletes, focusing on both hormonal and non-hormonal drugs. Hormonal substances such as anabolic steroids and growth hormones, and non-hormonal agents like diuretics and β2-agonists, are frequently abused. These practices are associated with severe side effects, including infections, cardiovascular complications, hormonal imbalances, psychological disorders, dependence, and even cases of death. The study emphasizes the need for stronger regulation, public awareness initiatives, and preventive strategies to mitigate the health risks associated with this growing trend.
Keywords: off-label use; performance enhancement; anabolic androgenic steroids; health risks off-label use; performance enhancement; anabolic androgenic steroids; health risks

Share and Cite

MDPI and ACS Style

Silva, V.; Madeira, R.; Joaquim, J.; Matos, C. Safety Implications of Off-Label Medication Use in Athletes: A Narrative Review. Medicines 2024, 11, 20. https://doi.org/10.3390/medicines11080020

AMA Style

Silva V, Madeira R, Joaquim J, Matos C. Safety Implications of Off-Label Medication Use in Athletes: A Narrative Review. Medicines. 2024; 11(8):20. https://doi.org/10.3390/medicines11080020

Chicago/Turabian Style

Silva, Vítor, Ricardo Madeira, João Joaquim, and Cristiano Matos. 2024. "Safety Implications of Off-Label Medication Use in Athletes: A Narrative Review" Medicines 11, no. 8: 20. https://doi.org/10.3390/medicines11080020

APA Style

Silva, V., Madeira, R., Joaquim, J., & Matos, C. (2024). Safety Implications of Off-Label Medication Use in Athletes: A Narrative Review. Medicines, 11(8), 20. https://doi.org/10.3390/medicines11080020

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop